Trial intelligence / Profile preview

Pentaglobin for sepsis in cirrhotic patients awaiting liver transplantation

2008-007989-34Phase 4Terminated

Sponsor
AOU Policlinico di Modena
Start
Feb 2009
Modality
Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Pentaglobin in sepsis, sponsored by AOU Policlinico di Modena. Primary endpoints: Recovery of clinical criteria for liver transplantation, Sepsis complications and mortality and 1 more. Started Feb 2009; status: terminated.

02

Drugs

Pentaglobin
03

Conditions

sepsis

Beyond the preview

Go deeper on 2008-007989-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007989-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call